Exclusive Interview: Volker Patzel of National Univerisity of Singapore | RTM2025

Dr. Volker Patzel is a German chemist who received his Ph.D. from the Ruprecht Karls University in Heidelberg and his MBA from the Steinbeis University in Berlin. He worked as postdoc at the German Cancer Research Center in Heidelberg, then as research group leader at the Max Planck Institute for Infection Biology in Berlin. He joined the National University of Singapore (NUS) in 2009 under the NUS-Cambridge Scheme. He has >50 publications, filed 16 patent families, and is (co)-founder of three biotech companies. His research focusses on RNA technologies, non-viral vector development, and therapeutic applications. He coordinates and teaches six courses on biotechnology and entrepreneurship.

Don't miss these valuable insights from Dr. Volker Patzel, and get ready for Vaccine World South East Asia  2025.
‍